NLM Logo

tazemetostat MeSH Supplementary Concept Data 2025


MeSH Supplementary
tazemetostat
Unique ID
C000593333
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000593333
Entry Term(s)
(1,1'-biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, hydrobromide (1:2)
(1,1'-biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2h-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, hydrochloride (1:1)
E 7438
E-7438 hydrobromide
E7438
EPZ-6438
EPZ-6438 dihydrobromide
EPZ-6438 monohydrobromide
EPZ-6438 monohydrochloride
EPZ-6438 trihydrochloride
EZ-438
EZ438
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide monohydrobromide
Tazverik
tazemetostat dihydrobromide
tazemetostat hydrobromide
tazemetostat hydrochloride
tazemetostat monohydrobromide
tazemetostat monohydrochloride
tazemetostat trihydrochloride
Registry Numbers
Q40W93WPE1
6P89T5M073
X536WKK41G
1L6UQ905WM
272LA4Y8S8
0
Related Numbers
1L6UQ905WM
272LA4Y8S8
6P89T5M073
X536WKK41G
Heading Mapped to
*Benzamides
*Biphenyl Compounds
*Morpholines
*Pyridones
Frequency
78
Note
a histone methyltransferase EZH2 inhibitor with antineoplastic activity
Source
Mol Cancer Ther. 2014 Apr;13(4):842-54.
Date of Entry
2014/12/04
Revision Date
2022/02/11
tazemetostat Preferred
tazemetostat hydrobromide Narrower
tazemetostat dihydrobromide Narrower
tazemetostat hydrochloride Narrower
tazemetostat trihydrochloride Narrower
EPZ-6438 trihydrochloride Narrower
EPZ-6438 monohydrochloride Narrower
EZ-438 Narrower
EPZ-6438 dihydrobromide Narrower
E 7438 Narrower
E-7438 hydrobromide Narrower
Tazverik Narrower
EPZ-6438 Narrower
EPZ-6438 monohydrobromide Narrower
page delivered in 0.004s